Pages that link to "Q81193479"

The following pages link to Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age (Q81193479):

Displaying 23 items.

• The value of improving failures within a cervical cancer screening program: an example from Norway (Q34021105) (← links)
• mRNA and DNA detection of human papillomaviruses in women of all ages attending two colposcopy clinics (Q34482073) (← links)
• Inhibitory effects of dobutamine on human gastric adenocarcinoma (Q34647590) (← links)
• Promoter methylation of p16(INK4A), hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence (Q35071090) (← links)
• Biomarkers of Cervical Dysplasia and Carcinoma (Q35495173) (← links)
• Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway (Q35927132) (← links)
• High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology (Q36118590) (← links)
• HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization. (Q36238070) (← links)
• High risk HPV DNA subtypes and E6/E7 mRNA expression in a cohort of colposcopy patients from Northern Italy with high-grade histologically verified cervical lesions (Q36383061) (← links)
• A comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men. (Q36514226) (← links)
• Chapter 10: New dimensions in cervical cancer screening (Q36584436) (← links)
• Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma (Q36706422) (← links)
• Antitumor activity of dobutamine on human osteosarcoma cells (Q36953612) (← links)
• Early detection of cervical carcinomas: finding an overall approach (Q37188108) (← links)
• RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. (Q37256248) (← links)
• New technologies in cervical cancer screening (Q37291434) (← links)
• Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. (Q37451826) (← links)
• Potential Role of E4 Protein in Human Papillomavirus Screening: a Review (Q42343538) (← links)
• Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts. (Q47599112) (← links)
• [Precancerous lesions of the uterine cervix: morphology and molecular pathology]. (Q53281884) (← links)
• HPV infection associated DNA damage correlated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China (Q90169005) (← links)
• Human Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae (Q90631538) (← links)
• The potential of RNA as a target for national screening of pre-cancer (Q92256596) (← links)